
Written by Sarah Bourdin
I was delighted to join IAS 2021 and participate in the discussion of the current hot topics in the HIV research world. The event was packed full of inspiring talks, essential debates, and discussions. I would argue we have some way to go technologically to fully facilitate open discussions virtually. There was a wealth of events, abstracts and material to discover, which was a little daunting. Having developed the unofficial routine and surveillance data guide for IAS, I now take on the mighty task of summarising my experience of IAS and what I saw as the hot topics of this year, you’re welcome.
Obviously, the most discussed topic, that was mentioned at almost every session, was COVID-19 and its impact. What arose from this, is that through its challenges and devastation, the pandemic is also an opportunity to rethink how services are being delivered. Many HIV prevention and treatment adaptions during COVID-19 were discussed, such as increased use of online tools, novel prevention and treatment methods and longer periods between clinic visits. Development of HIV self-testing during the COVID-19 pandemic is a good example of the use of digital and mHealth solutions to increase access, reach populations differently, and facilitate follow-up and linkage to care. See here for more abstracts on HIV self-testing and here for the outputs from the Self-Testing AfRica (STAR) Initiative published in the BMJ.
Along with COVID-19, the other hot topic at IAS was Differentiated Service Delivery (DSD), which aims to provide personalised care and population-based interventions. These topics are linked as the pandemic has highlighted the need for HIV services to be person centred. Sessions from implementation to lessons learned emphasised the importance of patient preferences and consideration of context- and community-specific needs at all stages to promote sustainability and reach those left behind. Additionally, the new WHO clinical and service delivery guidelines for HIV prevention, treatment and care recommend ART initiation in the community, the routine use of tracing lost patients and re-engagement efforts, expanded psychosocial services for adolescents, and integration of other chronic conditions (see session on the new guidelines for more). In line with the guidelines, MeSH presented two abstracts on the challenges and feasibility of tracing patients lost to follow up. Also mentioned in the new WHO consolidated guidelines, is the future role of viral load point of care tests and recency testing. IAS 2021 featured many sessions relating to the scale up of viral load monitoring ranging from novel methods such as lateral flow point-of-care-HIV-Combo tests, to improving viral load testing coverage during the COVID-19 pandemic and optimising integration of viral load testing into care.
During the Key Populations (KPs) session, experts discussed how current epidemiological and programmatic approaches for KPs in sub-Saharan Africa are insufficient, and call for improved understanding of local epidemiology and the effectiveness of interventions. Towards this aim, several abstracts were presented during IAS 2021. In South Africa researchers found that PrEP was cost saving for female sex workers (FSWs), and another study showed that initiations on PrEP among FSWs in Durban, South Africa increased but persistence was suboptimal and dropped greatly over time. Indeed, in Kenya researchers found that younger individuals and KPs had worse retention on PrEP compared to the general population. Another abstract of interest describes a study where providing more choice based on participant preferences improved retention and adherence among young FSWs in Kampala, Uganda. Several abstracts described reasons for KP patients being lost to follow up and potential solutions for reengagement. Scaling up of patient-centred research and interventions, defining populations, expanding options and biomedical service, capacity building, task sharing, and evidence-based budgeting were all cited as ways forward post-IAS.
There was of course a plethora of other fascinating topics at IAS 2021, but these three are what I found to be the most important and interesting. I look forward to seeing where these new ideas, connections and enthusiasm take us as we go towards the goal of global elimination by 2030. Personally, I am excited for the opportunity to meet researchers in person at future conferences, and also hope to see increased inclusion of patients & communities in research and better communication, cohesion and collaboration between research groups. If you’d like to keep up to date with how we will be doing just that, then follow our twitter!